457 items related to 'SMC'
(Page 4 of 23)
-
Resources: Journal article :
Effectiveness of sulfadoxine–pyrimethamine plus amodiaquine and dihydroartemisinin–piperaquine for seasonal malaria chemoprevention in Uganda
No evidence for selection of antimalarial drug resistance was found in this cluster-randomised controlled trial to assess the effectiveness of a standard and alternative drug regimen for seasonal…
-
World Malaria Report 2024: Progress underscores need for accelerated, data-driven action
This year's World Malaria Report reflects on gains made — but calls for further action as other threats arise.
-
Resources: Presentation :
Lessons from using SALAMA health campaign management platform to implement and optimise SMC in Mozambique
Digitalisation of seasonal malaria chemoprevention (SMC) across all districts of Nampula province during the 2023/24 SMC campaign proved effective for near-real-time data visualisation and allowed…
-
ASTMH 2024 Publications
-
ASTMH 2023 Posters and presentations
-
ASTMH 2023 Publications
-
ASTMH 2024 Posters and presentations
-
Catalysing change: The crucial role of philanthropy in eliminating malaria
-
International Day of Women and Girls in Science 2024
-
Pioneering solutions for community health: Africa's trailblazers
-
20 years of impact: Saving lives, transforming communities
-
Q&A with our experts: SDG 3 progress on maternal and child health
-
Top reads of 2023
-
The impact of Global Fund investment in fighting malaria
-
Malaria Consortium Mozambique
-
The groundbreaking immune dynamics study in Uganda
-
Resources: Presentation :
Estimating the impact of seasonal malaria chemoprevention: A modelling framework using routine data sources in Burkina Faso
Analysis of malaria prevalence data has demonstrated that seasonal malaria chemoprevention is having a significant impact in Burkina Faso.
-
Impact report 2024
-
Resources: Annual review :
Impact report 2024
We reflect on Malaria Consortium's key achievements in advancing malaria and public health programmes over the last 12-months with a focus on improving healthcare access for equitable health outcomes.
-
Resources: Poster :
Assessing the safety and tolerability of five months’ repeated doses of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine plus amodiaquine when used for seasonal malaria chemoprevention in children under five in Uganda
Dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine plus amodiaquine are both safe when used for seasonal malaria chemoprevention among children under five in Karamoja region, Uganda.